Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | 27T51 |
Trade Name | |
Synonyms | 27T-51|27T 51 |
Drug Descriptions |
Limited information is currently available on 27T51, a putative chimeric antigen receptor (CAR)-T cell therapy targeting MUC16 (Jul 2024). |
DrugClasses | MUC16 Targeted Therapy 10 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
27T51 | 27T51 | 0 | 1 |
27T51 + Bevacizumab + Cemiplimab | 27T51 Bevacizumab Cemiplimab | 0 | 1 |
27T51 + Cemiplimab | 27T51 Cemiplimab | 0 | 1 |